Affiliation:
1. Department of Ophthalmology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder impacting cognition, function, and behavior in the elderly population. While there are currently no disease-modifying agents capable of curing AD, early diagnosis and management in the preclinical stage can significantly improve patient morbidity and life expectancy. Currently, the diagnosis of Alzheimer’s disease is a clinical one, often supplemented by invasive and expensive biomarker testing. Over the last decade, significant advancements have been made in our understanding of AD and the role of ocular tissue as a potential biomarker. Ocular biomarkers hold the potential to provide noninvasive and easily accessible diagnostic and monitoring capabilities. This review summarizes current research for detecting biomarkers of Alzheimer’s disease in ocular tissue.
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference118 articles.
1. Tahami Monfared, A.A., Byrnes, M.J., White, L.A., and Zhang, Q. (2022). Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurol. Ther., 1–17.
2. Prince, M., Guerchet, M., and Prina, M. (2015). The Epidemiology and Impact of Dementia-Current State and Future Trends, WHO Thematic Briefing.
3. Global estimates on the number of persons across the Alzheimer’s disease continuum;Gustavsson;Alzheimer’s Dement.,2022
4. Visual features in Alzheimer’s disease: From basic mechanisms to clinical overview;Neural Plast.,2018
5. The Eye As a Biomarker for Alzheimer’s Disease;Lim;Front. Neurosci.,2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献